InsidersTradesSigma
Follow the Tokai Pharmaceuticals Inc share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €7.4bn. The latest transaction was disclosed on 8 January 2016 (Levée d'options). Among the most active insiders: Morrison Jodie Pope. The full history is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Tokai Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for hormone-dependent cancers. It is listed on NASDAQ under the ticker TKAI.